AusVaxSafety surveillance is a collaborative initiative led by NCIRS and involves vaccine safety experts, state and territory public health systems, general practitioners and children’s hospitals across Australia. It is funded by the Australian Government Department of Health. AusVaxSafety partners with and makes use of several computer-based surveillance systems, Vaxtracker, SmartVax, and STARSS, which send SMSs or web-based surveys to parents and carers seeking information on how their child felt after receiving the influenza vaccine.
Surveillance is currently conducted for influenza vaccine in children aged 6 months to <5 years and pertussis-containing booster vaccine in children aged 12 months to <7 years.
Data compiled by AusVaxSafety are summarised in reports for the Australian Government Department of Health (HEALTH) Immunisation Branch and the Therapeutic Goods Administration (TGA) and shared with participating state and territory health departments. Reports are written and distributed weekly for influenza vaccine-associated reactions (during influenza season only) and monthly for pertussis-containing vaccine-associated reactions.
Current vaccine safety surveillance
AusVaxSafety influenza vaccine surveillance numbers as of 14 August 2016
AusVaxSafety pertussis-containing vaccine surveillance numbers as of 11 September 2016
This surveillance confirms that the vaccines currently in use in Australian children have a good and acceptable safety profile.
For 2015 influenza vaccine results, please refer to our Eurosurveillance article: Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015.
For more information
Last updated 1st September 2016